CHARLES RIVER LABORATORIES (CRL)

US1598641074 - Common Stock

269.37  +3.93 (+1.48%)

After market: 269.37 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

CHARLES RIVER LABORATORIES

NYSE:CRL (3/27/2024, 8:06:55 PM)

After market: 269.37 0 (0%)

269.37

+3.93 (+1.48%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap13.83B
Shares
PE25.29
Fwd PE24.25
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

CRL Daily chart

Company Profile

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides research models required in the research and development of new drugs, devices, and therapies. The company is headquartered in Wilmington, Massachusetts and currently employs 20,000 full-time employees. The company went IPO on 2000-06-23. The firm provides research models required in research and development of new drugs, devices, and therapies. The firm operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the research models, research model services, and research and cells solutions businesses. The DSA segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. The Manufacturing segment includes Microbial Solutions and Biologics Solutions (Biologics).

Company Info

CHARLES RIVER LABORATORIES

251 Ballardvale St

Wilmington MASSACHUSETTS 01887

P: 17812226000

CEO: James C. Foster

Employees: 20000

Website: https://www.criver.com/

CRL News

News Image14 hours ago - Market News VideoRB Global Larger Than S&P 500 Component Charles River Laboratories International
News Imagea day ago - Charles River Laboratories International, Inc.Charles River Laboratories Publishes 2023 Corporate Citizenship Report
News Image3 days ago - ChartmillThese S&P500 stocks are gapping in today's session

Monday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

News Image7 days ago - Charles River Laboratories International, Inc.Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
News Image14 days ago - Charles River Laboratories International, Inc.Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
News Image16 days ago - Charles River Laboratories International, Inc.Charles River Laboratories to Present at Barclays Global Healthcare Conference

CRL Twits

Here you can normally see the latest stock twits on CRL, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example